Resmed Inc

Common Name
Resmed
Country
United States
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,600
Ticker
RMD
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producin...

Resmed's GHG Emissions Data Preview

In 2023, Resmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Resmed has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Resmed’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Resmed’s data sources below and access millions more through our Disclosure Search.

a. Resmed's Sustainability Report 2023
a. Resmed's Sustainability Report 2023

Insights into Resmed's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Resmed amounted to 28,392 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Resmed increased by 13.3%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Resmed's Scope 1 Emissions Over Time

20212022202301.5 k3 k4.5 k6 ktCO2e+55%+19%
  • Total Scope 1
  • Year-over-Year Change

What are Resmed's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Resmed were 4,453 metric tons of CO₂ equivalent (tCO₂e). a

Has Resmed reduced its Scope 1 emissions over time?

Since 2021, Resmed's Scope 1 emissions have increased by 84.16%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Resmed's Scope 1 emissions increased by 18.97%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Resmed's Scope 2 emissions?

In 2023, Resmed reported Scope 2 greenhouse gas (GHG) emissions of 23,939 tCO₂e without specifying the calculation method. a

Has Resmed reduced its Scope 2 emissions over time?

Since 2021, Resmed's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Resmed 's emissions have plateaued with no significant change in its energy consumption footprint. a

Compared to the previous year (2022), Resmed's Scope 2 emissions (Unspecified Calculation Method) rose by 12.3% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Resmed use for Scope 2 reporting?

In 2023, Resmed reported its Scope 2 emissions using an unspecified methodology. a

Resmed's Scope 2 Emissions Over Time

20212022202306 k12 k18 k24 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Resmed’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Resmed reported Scope 1 greenhouse gas (GHG) emissions of 4,453 tCO₂e and total revenues of USD 4,223 millions. This translates into an emissions intensity of 1.05 tCO₂e per millions USD. a

Resmed's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000100,0001,000,000Scope 1 Emissions (tCO2e)2005002,00010,00050,000Revenues (Millions of USD)IncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MAzentaYear: 2023Scope 1: 14,399 tCO2eRevenue: $M 665Scope 1 Intensity: 21.65 tCO2e/$MAptargroupYear: 2023Scope 1: 24,660 tCO2eRevenue: $M 3,487Scope 1 Intensity: 7.07 tCO2e/$MAvantorYear: 2023Scope 1: 26,095 tCO2eRevenue: $M 6,967Scope 1 Intensity: 3.75 tCO2e/$MBecton Dickinson and CoYear: 2023Scope 1: 162,475 tCO2eRevenue: $M 19,372Scope 1 Intensity: 8.39 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MWest Pharmaceutical ServicesYear: 2024Scope 1: 31,327 tCO2eRevenue: $M 2,893Scope 1 Intensity: 10.83 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MCooper CompaniesYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 3,895Scope 1 Intensity: 14.93 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MZoetisYear: 2023Scope 1: 111,637 tCO2eRevenue: $M 8,544Scope 1 Intensity: 13.07 tCO2e/$MHenry ScheinYear: 2024Scope 1: 33,555 tCO2eRevenue: $M 12,673Scope 1 Intensity: 2.65 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MResmedYear: 2023Scope 1: 4,453 tCO2eRevenue: $M 4,223Scope 1 Intensity: 1.05 tCO2e/$M

How does Resmed's GHG emissions intensity compare to its peers?

In 2023, Resmed reported a Scope 1 emissions intensity of 1.05 tCO₂e per millions USD. Compared to the peer group median of 3.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Resmed rank on GHG emissions intensity within its industry?

In 2023, Resmed ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Resmed among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Resmed's GHG Emissions Dataset?
Sign Up